2018-12-01
Rebuttal Letter to the Editor Kloosterboer et al., Therapeutic Drug Monitoring 2018;40: 344-350
Publication
Publication
Therapeutic Drug Monitoring
,
Volume 40
-
Issue 6
p. 762
| Additional Metadata | |
|---|---|
| Persistent URL | dx.doi.org/10.1097/FTD.0000000000000560, hdl.handle.net/1765/112347 |
| Journal | Therapeutic Drug Monitoring |
| Citation |
Kloosterboer, S.M, de Winter, B.C.M, Bahmany, S, Al-Hassany, L. (Linda), Dekker, A. (Annet), Dieleman, G.C, … Koch, B.C.P. (2018). Rebuttal Letter to the Editor Kloosterboer et al., Therapeutic Drug Monitoring 2018;40: 344-350. Therapeutic Drug Monitoring, 40(6). doi:10.1097/FTD.0000000000000560
|